Plexiform Bioscience is the biopharmaceuticals company that develops eye drop formula targeted to treat directly the retina.
Plexiform Bioscience has raised $250K in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Plexiform Bioscience is headquartered in Dover, United States.
Plexiform Bioscience is the biopharmaceuticals company that develops eye drop formula targeted to treat directly the retina.
Plexiform Bioscience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Plexiform Bioscience — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/plexiform-bioscience. Accessed August 1, 2026.
VCBacked. (2024). Plexiform Bioscience — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/plexiform-bioscience
{{cite web |title=Plexiform Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/plexiform-bioscience |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated